Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency

References

• Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2:313–9.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, . Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005–11.
   PubMed Web of Science ®Google Scholar
• Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery. 2004;55:1185–93.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932–7.
   PubMed Web of Science ®Google Scholar
• Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30:215–22.
   PubMed Web of Science ®Google Scholar
• Meuleman N, Vanhaelen G, Tondreau T, Lewalle P, Kwan J, Bennani J, . Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica. 2008;93:e11–13.
   Web of Science ®Google Scholar
• Mankani MH, Kuznetsov SA, Marshall GW, Robey PG. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A. 2008;14:1949–58.
   PubMed Web of Science ®Google Scholar
• Mankani MH, Kuznetsov SA, Shannon B, Nalla RK, Ritchie RO, Qin Y, . Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol. 2006;168:542–50.
   PubMed Web of Science ®Google Scholar
• Mankani MH, Kuznetsov SA, Wolfe RM, Marshall GW, Robey PG. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells. 2006;24:2140–9.
   PubMed Web of Science ®Google Scholar
• Kuznetsov SA, Huang KE, Marshall GW, Robey PG, Mankani MH. Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphate. Biomaterials. 2008;29:4211–6.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair, current views. Stem Cells. 2007;25:2896–902.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang S, Yu Z, Hoyt RF Jr, Sachdev V, Vincent P, . Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun. 2009;390:902–7.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076–84.
   PubMed Web of Science ®Google Scholar
• Sadan O, Melamed E, Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther. 2009;9:1487–97.
   PubMed Web of Science ®Google Scholar
• Le BK, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:321–34.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy. 2008;10:771–4.
   PubMed Web of Science ®Google Scholar
• Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, . Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110:2764–7.
   PubMed Web of Science ®Google Scholar
• Le BK, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
   PubMed Web of Science ®Google Scholar
• Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010;16:118–29.
   PubMed Web of Science ®Google Scholar
• Le BK, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262:509–25.
   PubMed Web of Science ®Google Scholar
• Pistoia V, Raffaghello L. Potential of mesenchymal stem cells for the therapy of autoimmune diseases. Expert Rev Clin Immunol. 2010;6:211–8.
   PubMed Web of Science ®Google Scholar
• Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, . The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler. 2010;16:503–10.
   PubMed Web of Science ®Google Scholar
• Li Y, Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett. 2009;456:120–3.
   PubMed Web of Science ®Google Scholar
• Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11:377–91.
   PubMed Web of Science ®Google Scholar
• van den Berk LC, Figdor CG, Torensma R. Mesenchymal stromal cells: tissue engineers and immune response modulators. Arch Immunol Ther Exp (Warsz). 2008;56:325–9.
   PubMed Web of Science ®Google Scholar
• Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. Micro-RNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med. 2009;7:20.
   PubMed Web of Science ®Google Scholar
• Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, . Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res. 2002;62:3581–6.
   PubMed Web of Science ®Google Scholar
• Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863–8.
   PubMed Web of Science ®Google Scholar
• Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, . DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:3.
   PubMed Web of Science ®Google Scholar
• Goessler UR, Bugert P, Bieback K, Stern-Straeter J, Bran G, Sadick H, . In vitro-analysis of integrin-expression in stem-cells from bone marrow and cord blood during chondrogenic differentiation. J Cell Mol Med. 2009;13:1175–84.
   PubMed Web of Science ®Google Scholar
• Goessler UR, Bugert P, Bieback K, Stern-Straeter J, Bran G, Hormann K, . Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. Int J Mol Med. 2008;21:271–9.
   PubMed Web of Science ®Google Scholar
• Lal H, Verma SK, Foster DM, Golden HB, Reneau JC, Watson LE, . Integrins and proximal signaling mechanisms in cardiovascular disease. Front Biosci. 2009;14:2307–34.
   Web of Science ®Google Scholar
• Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, . Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells. 2007;25:1966–74.
   PubMed Web of Science ®Google Scholar
• Markov V, Kusumi K, Tadesse MG, William DA, Hall DM, Lounev V, . Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev. 2007;16:53–73.
   PubMed Web of Science ®Google Scholar
• Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, . Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells. 2005;23:584–93.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857–902.
   PubMed Web of Science ®Google Scholar
• Magnon C, Frenette PS. Hematopoietic stem cell trafficking. StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008; Jul 14.
   Google Scholar
• Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, . Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat. 2008;110:39–49.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H, . TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2009;69:37–44.
   PubMed Web of Science ®Google Scholar
• Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM. Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol. 2008;40:1685–702.
   PubMed Web of Science ®Google Scholar
• Fedak PW, Moravec CS, McCarthy PM, Altamentova SM, Wong AP, Skrtic M, . Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation. 2006;113:238–45.
   PubMed Web of Science ®Google Scholar
• Cicha I, Goppelt-Struebe M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors. 2009;35:200–8.
   PubMed Web of Science ®Google Scholar
• Rachfal AW, Brigstock DR. Structural and functional properties of CCN proteins. Vitam Horm. 2005;70:69–103.
   PubMed Web of Science ®Google Scholar
• Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, . Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE. 2009;4:e6743.
   PubMed Web of Science ®Google Scholar
• Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, . PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307.
   PubMed Web of Science ®Google Scholar
• Wagner EF. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis. 2010;69(Suppl 1):i86–8.
   Google Scholar
• Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 2005;208:126–40.
   PubMed Web of Science ®Google Scholar
• Maehata Y, Takamizawa S, Ozawa S, Izukuri K, Kato Y, Sato S, . Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol. 2007;26: 371–81.
   PubMed Web of Science ®Google Scholar